You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
川寧生物(301301.SZ):硫氰酸紅黴素需求穩定 一直處於滿產滿銷的狀態
格隆匯 08-06 07:22

格隆匯8月6日丨川寧生物(301301.SZ)近日在接待機構投資者調研時表示,目前頭孢類中間體價格逐步恢復,市場處於緊缺狀態,頭孢的需求量明顯增加,預計未來頭孢類中間體價格持續向好,同時公司根據市場需求也可以進行調整生產7-ADCA等其他頭孢類中間體。

公司青黴素類中間體產品價格將延續目前良好勢頭,產品價格也會比較穩定。以印度的生產條件很難達到國內的市場價格,預計後續青黴素類中間體有望維持今年價格。

硫氰酸紅黴素的需求穩定,一直處於滿產滿銷的狀態,預計未來價格還會繼續維持目前的價格區間。公司通過工藝不斷提升,自動化升級改造,未來更具有成本優勢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account